Target intelligence / Profile preview

Sodium-dependent serotonin transporter (SERT)

Target
SERT
Molecular classification
Transporter, Neurotransmitter sodium symporter family (NSS), Membrane protein
01

Overview

The sodium-dependent serotonin transporter (SERT), encoded by the SLC6A4 gene, is a membrane protein responsible for the reuptake of the neurotransmitter serotonin from the synaptic cleft back into presynaptic neurons. This process is essential for terminating serotonergic signaling and recycling serotonin in a sodium-dependent manner. SERT operates via cotransporting one Na+ ion with each molecule of serotonin in exchange for one K+ ion and possibly one proton. It plays a critical role in maintaining central nervous system homeostasis of serotonin levels. The transporter is also present in platelets where it regulates blood levels of serotonin and contributes to platelet aggregation. Dysregulation or genetic variation in SERT has been implicated in several neuropsychiatric conditions including depression, anxiety disorders, OCD, PTSD, substance use disorders, and others. Many antidepressant drugs—including SSRIs and tricyclic antidepressants—exert their therapeutic effects by inhibiting this transporter[1][3][5].

Other names
SLC6A45-HTTSerotonin transporterSolute carrier family 6 member 4
02

Mechanism of action

Inhibition of serotonin reuptake by binding to the transporter and blocking its function[3][4]

03

Biological functions

Neurotransmitter transportSerotonin reuptakeRegulation of synaptic serotonin levelsPlatelet aggregation
04

Disease associations

Major depressive disorderAnxiety disordersObsessive-compulsive disorder (OCD)Substance use disordersPost-traumatic stress disorder (PTSD)
05

Safety considerations

Risk of serotonin syndrome when combined with other serotonergic agents
06

Interacting drugs

Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, sertraline, paroxetine, citalopram, escitalopram

1 more in the full profile.

07

Biomarkers

SLC6A4 gene polymorphisms (e.g., 5HTTLPR) for susceptibility to depression and response to SSRIs[3]

Beyond the preview

Go deeper on Sodium-dependent serotonin transporter (SERT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent serotonin transporter (SERT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call